WuXi AppTec's stock price surged 100% to an all-time high, as investors bet on its continued core position in the global drug supply chain.
WuXi AppTec's stock price hit a record high last week, doubling its January level, despite the U.S. Pentagon listing it as a Chinese military company, which could lead some American clients to withdraw business. Investors continue to pour in, betting on the company's core position in the global supply of obesity, cancer, and other drugs. Previously, WuXi AppTec's first-half results exceeded analysts' expectations and it significantly raised its full-year guidance. It also obtained a preliminary injunction against the Pentagon's accusations, which investors generally interpreted as a positive sign.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
The Nikkei 225 index fell 2% from its previous close, currently trading at 59,918.04.
-
2
What was the initial offering price of DODO? Introduction to the DODO token issuance price
-
3
How to buy and sell REV3L token? Which exchanges is REV3L listed on?
-
4
Yemeni government forces say 173 Houthi fighters were killed or wounded in clashes across multiple fronts
-
5
From Coinbase Perpetual Contract Account Setup to Anti-Liquidation: A Practical Masterclass After the CFTC's Historic Approval 2026
-
6
Central Bank of Brazil Official's Remarks on Stablecoin Money Laundering Risks Spark Strong Market Backlash
-
7
Bitcoin slips below $65,000, weighed down by U.S. stock declines driven by AI sentiment and NVIDIA earnings expectations
-
8
CNN: U.S. intelligence warns Iran may plot dirty bomb or chemical attack in Washington
-
9
SK Hynix is down 8.22% from its previous close, currently trading at ₩1,116,000.
-
10
NVIDIA: Lambda deploys co-packaged optics switches in 10,000+ GPU cluster
Markets Today
Recommended Reading





